A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes (Q36449523)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes |
scientific article |
Statements
1 reference
A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes (English)
1 reference
J Rosenstock
1 reference
P D Home
1 reference
J Larsen
1 reference
C Koenen
1 reference
G Schernthaner
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference